Bloomage BioTechnology Corporation Limited (SHA:688363)

Market Cap	16.14B -30.6%
Revenue (ttm)	3.95B -22.4%
Net Income	254.82M +677.0%
EPS	0.54 +698.6%
Shares Out	478.36M
PE Ratio	62.64
Forward PE	39.59
Dividend	0.19 (0.57%)
Ex-Dividend Date	Jul 14, 2025

Volume	4,175,060
Open	33.65
Previous Close	33.75
Day's Range	33.53 - 34.78
52-Week Range	32.92 - 61.85
Beta	0.51
Analysts	Hold
Price Target	40.53 (+16.8%)
Earnings Date	Aug 25, 2026

About SHA:688363

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 3,698
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688363

Financial Performance

In 2025, SHA:688363's revenue was 4.20 billion, a decrease of -21.82% compared to the previous year's 5.37 billion. Earnings were 292.06 million, an increase of 67.59%.

Analyst Summary

According to 9 analysts, the average rating for 688363 stock is "Hold." The 12-month stock price target is ¥40.53, which is an increase of 16.80% from the latest price.

Price Target

¥40.53

(16.80% upside)

Analyst Consensus: Hold